Clinical Trial

Fatty Liver in Long Standing Cholecystectomy

Study acronym: MAFLD-Chole St
Not Yet Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated December 16, 2025 (before its estimated June 30, 2026 completion). Its status may not reflect the trial's current state.
Summary
This observational study aims to evaluate the association between long-term cholecystectomy and the development of metabolic dysfunction-associated fatty liver disease (MAFLD) in adult patients. The study will assess the prevalence and severity of hepatic steatosis in individuals who underwent cholecystectomy several years earlier and compare clinical, metabolic, and biochemical parameters to identify potential risk factors. The goal is to determine whether cholecystectomy contributes to metabolic alterations that increase the likelihood of MAFLD in the long term.
Trial Details
NCT Number NCT07284004
Lead Sponsor Yasmeen Ahmed Farrag Ahmed
Conditions Metabolic Dysfunction-Associated Fatty Liver Disease (MAFLD)-Post-cholecystectomy Metabolic Changes -Hepatic Steatosis
Enrollment 100 participants
Start Date 2025-12-30
Primary Completion 2026-06-30 (estimated)
Study Completion 2026-12-30 (estimated)
Updated on ClinicalTrials.gov 2025-12-16